These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 27387204

  • 1. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    Li L, Song X, Liu R, Li N, Zhang Y, Cheng Y, Chao H, Wang L.
    BMC Cancer; 2016 Jul 07; 16():403. PubMed ID: 27387204
    [Abstract] [Full Text] [Related]

  • 2. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
    Doll KM, Donnelly E, Helenowski I, Rosenbloom L, Small W, Schink JC, Lurain JR.
    Am J Clin Oncol; 2014 Feb 07; 37(1):30-4. PubMed ID: 22992622
    [Abstract] [Full Text] [Related]

  • 3. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z, Wu L, Yao H, Sun Y, Li X, Li B, Zhang R, Ma S, Huang M.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar 07; 50(3):198-203. PubMed ID: 26268410
    [Abstract] [Full Text] [Related]

  • 4. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.
    Int J Gynecol Cancer; 2013 Mar 07; 23(3):567-75. PubMed ID: 23385284
    [Abstract] [Full Text] [Related]

  • 5. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH, Wu HG, Ha SW, Lee HP, Kang SB, Song YS, Park NH, Kim JW, Park IA, Kim BH.
    Gynecol Oncol; 2007 Jan 07; 104(1):152-7. PubMed ID: 16935323
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K, Kitahara Y, Satoh T, Takei Y, Takano M, Nagao S, Sekiguchi I, Suzuki M.
    World J Surg Oncol; 2016 Jun 29; 14(1):173. PubMed ID: 27356862
    [Abstract] [Full Text] [Related]

  • 7. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    Zhang H, Yu R, Zhang L, Wang R, Xiao L.
    BMC Cancer; 2022 Feb 23; 22(1):202. PubMed ID: 35193525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
    Lacorre A, Merlot B, Garabedian C, Narducci F, Chereau E, Resbeut M, Minsat M, Leblanc E, Houvenaeghel G, Lambaudie E.
    Eur J Surg Oncol; 2016 Mar 23; 42(3):376-82. PubMed ID: 26725307
    [Abstract] [Full Text] [Related]

  • 10. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X, Xu H, Wang Z, Liu R, Hu T, Li S.
    Am J Clin Oncol; 2016 Dec 23; 39(6):604-608. PubMed ID: 24937635
    [Abstract] [Full Text] [Related]

  • 11. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W, Tantipalakorn C, Charoenkwan K, Srisomboon J.
    Asian Pac J Cancer Prev; 2014 Dec 23; 15(2):887-90. PubMed ID: 24568513
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP, Li B, Wang YT, Liu SH, Zhang YN, Zhang R, Bai P, Li XG, Wu LY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr 25; 53(4):248-256. PubMed ID: 29747270
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.
    Mabuchi S, Okazawa M, Isohashi F, Matsuo K, Ohta Y, Suzuki O, Yoshioka Y, Enomoto T, Kamiura S, Kimura T.
    Gynecol Oncol; 2011 Nov 25; 123(2):241-7. PubMed ID: 21820708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y, Gorchev G.
    J BUON; 2007 Nov 25; 12(1):57-63. PubMed ID: 17436403
    [Abstract] [Full Text] [Related]

  • 18. Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.
    Haque W, Verma V, Fakhreddine M, Hatch S, Butler EB, Teh BS.
    Gynecol Oncol; 2017 Jan 25; 144(1):28-33. PubMed ID: 27784533
    [Abstract] [Full Text] [Related]

  • 19. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun 25; 47(6):452-7. PubMed ID: 22932113
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
    Hosaka M, Watari H, Kato T, Odagiri T, Konno Y, Endo D, Mitamura T, Kikawa S, Suzuki Y, Sakuragi N.
    J Surg Oncol; 2012 May 25; 105(6):612-6. PubMed ID: 22065519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.